VJHemOnc Podcast cover image

T-cell lymphoma highlights at ASH 2022: unmet needs, clinical trial updates & future outlooks

VJHemOnc Podcast

00:00

Introduction

The speakers discuss the poor prognosis of T-cell lymphoma, highlighting the importance of real world data and a prospective study with over 10 years of follow-up. They emphasize the need to consider relapse rates in treatment decisions.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app